2024-09-20 20:13:02
The United States gave the order this Friday primary nasal spray flu vaccine that patients will be able to manage themselves without the help of a professional. This is FluMist, manufactured by the AstraZeneca group and approved for many years by the United States Food and Drug Administration (FDA) for use in people between 2 and 49 years of age.
“It is a new option to get a safe and effective vaccine against seasonal influenza more comfortable, flexible and accessible for individuals and families,” explained Peter Marks, head of the FDA.
This option will be available starting next autumnAstraZeneca has indicated. However, a prescription will still be required to receive the vaccine, the FDA has explained.
The vaccine will have instructions for usewhich was examined in a study to ensure clarity. They emphasize the fact that minors should not be taking care of you on their own, but their parents or guardians can do so.
This order is “an important step to take vaccines are more accessible», announced Iskra Reic, from AstraZeneca.
The main side effect of the vaccine, which contains a live attenuated virus, it could be fever in children between 2 and 6 years.
According to the company, they are already distributed almost 200 million needles all over the world.
#United #States #mandates #personal #influenza #vaccine